Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with ...

GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for the continued development and ...

In the course of the ALS development program, however, dexpramipexole was observed to produce a significant and targeted depletion of eosinophils in the blood of ALS patients 4. Eosinophils are ...

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 70+ ...

Atopic dermatitis manifests differently in patients with darker skin color, according to the companies, including subtler ...

Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab ...

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved ...

Eosinophils tend to be high in patients whose ... Sanofi also said today that it is expanding the development of asthma candidate lunsekimig, a bispecific antibody targeting TSLP and IL-13 ...

A groundbreaking study led by National Jewish Health researchers suggests that the skin may serve as a potential biomarker ...

A groundbreaking study led by National Jewish Health researchers suggests that the skin may serve as a potential biomarker ...

Ohtuvayre's rapid US launch boosts Verona's growth with Q1 2025 sales up 95%. Read more on VRNA stock's blockbuster potential ...